Homeopathic Drug Recall: Candida Albicans Remedy for Manufacturing Quality Issues
Washington Homeopathic Products is recalling Candida Albicans homeopathic remedy due to manufacturing quality control violations. The voluntary recall affects 1,047 bottles distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses, injuries, or identified contamination. The recall is voluntary and precautionary, addressing manufacturing quality control deviations without demonstrated patient harm.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Candida Albicans homeopathic remedy in multiple potencies (9C, 10C, 12C, 13C, 14C, 15C, 16C, 19C, 24C, 25C, 26C, 30C, 200C, 14X, 15X, 16X, 20X, 288X, and 30X) supplied as liquid pellets. The recall involves 1,047 glass amber bottles with lot numbers 17759, 18479, and 18133.
The recall was initiated due to current good manufacturing practice (cGMP) deviations. Washington Homeopathic Products voluntarily initiated this recall upon discovery of the manufacturing process deviations.
The product was distributed nationwide in the United States. No illnesses, injuries, or adverse events have been reported in connection with this product.
The recalled product
- Product
- Candida Albicans, Potency: 9C, 10C, 12C, 13C, 14C 15C 16C, 19C, 24C, 25C, 26C, 30C, 200C, 14X, 15X, 16X, 20X, 288X, 30X, Liquid Pellets, OTC, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic
- Hazard
- manufacturing-quality
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot # 17759
- 18479
- 18133
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27